The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
about
Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysisDevelopments in the classification and treatment of the juvenile idiopathic inflammatory myopathiesCardiac involvement in adult and juvenile idiopathic inflammatory myopathiesPediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies.Idiopathic inflammatory myopathies.Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes.Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis.Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis.Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies.Brief Report: Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset With Disease Course in Juvenile Myositis.PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome.The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomesMyositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.Consensus-based recommendations for the management of juvenile dermatomyositis.Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.The Clinical Features of Myositis-Associated Autoantibodies: a Review.Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.Serological subsets of juvenile idiopathic inflammatory myopathies--an update.Race, Income, and Disease Outcomes in Juvenile Dermatomyositis.The cutaneous and systemic findings associated with nuclear matrix protein-2 antibodies in adult dermatomyositis patients.Autoimmune Myopathies.Monitoring change in volume of calcifications in juvenile idiopathic inflammatory myopathy: a pilot study using low dose computed tomography.A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity.Juvenile polymyositis associated with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibody in a 13-year-old girl.Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.Toll-Like Receptor 4-Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Inflammatory Development of Polymyositis by Mediating Interferon-γ and Interleukin-17A in Humans and Experimental Autoimmune Myositis Mouse Model.213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature.Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review.Autoantibodies in children with juvenile dermatomyositis: A single centre experience from North-West India.Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.Current Classification and Management of Inflammatory Myopathies.Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologists.Bench to bedside review of myositis autoantibodies.
P2860
Q21090635-4EA523BF-C4DA-4CF9-8B6A-1003916C7D75Q26863125-0556BF2A-803A-426C-A7D2-3243C942C724Q28079786-E788DF89-DE1E-4EB9-B78E-C115DC271AADQ33620443-5613DA3F-C866-475E-9B76-91E10AC71AB6Q33924451-74092901-3332-46AD-A74C-A00E17676AB3Q34490287-7969775E-4540-44CB-B90A-80C8457E09E4Q35153832-EED99AEE-57E0-49DE-828A-502ADFC77A81Q35153899-73F31E9C-7C1A-472D-99FC-A63EBDDBBD25Q36283423-13BA67DC-C71C-4CAA-9AE5-2A2B1814A461Q36619819-8E05F45F-0DA9-4C9B-8EC1-055CB5BA4CECQ36788809-EEA7101E-11A9-4DB4-AE28-218C2751F5A2Q37022721-C31BEA31-502C-48B9-B239-17D91064BBD5Q37368405-4642ED5C-1546-446E-AF7C-DF9E6DCAE9D8Q37388175-EE8E74BE-5AF1-45CC-A528-642475580014Q37427265-7966891E-2E49-4C0D-B999-5099DA4A65FBQ37617000-A03AA215-92D9-4FD6-91C4-D79E67C95058Q37674765-F5F842B2-5DD7-4A0B-9F56-AFF965DA262EQ38534871-85CA207A-7CBB-4049-BF13-25AF701C3943Q38596370-690D113D-22DF-44DA-9E7F-CBD03FA6F864Q38597575-CD0503D5-B62C-490C-BE71-2541655ED0C8Q38603422-7BA5A79B-9231-4626-A64E-86C7E818F6B8Q38646384-8C26EFEE-80EF-4589-AB83-B1EBDD44664FQ38664251-DC461505-7737-4E5E-BBF1-C246D5FEA8F2Q38836830-A903D253-B81E-4DB4-AE86-E504DE1FAB3DQ38995102-0604B6F9-08C6-4D73-A00F-4517224E6610Q39030495-9E28291A-DCE8-43AA-8FE9-E404A5AC9BA3Q39148036-335567B6-8AFF-4E57-A3EF-E2910C822A5FQ39247284-31360362-6FC1-4FF6-8E27-057558F50181Q40168656-7E215508-026D-4894-9BF6-72F4DA38266AQ40747808-00E1CBB1-0D64-4B25-A9D6-A0C8F6F15523Q42292003-FD9146D2-D843-4D24-8D9F-81227C4F35ECQ42365042-52DEC959-639B-4477-B398-919DC0B9009EQ42632915-199802DC-DC34-4268-9EB0-4F177CBD6792Q46895096-FC5EBCF9-1EB5-42C0-94C5-CE0A3B3AF9CFQ47593445-62214A9F-C06E-43A9-AF9B-0DFD826B6CA3Q51090216-1BB7BE8C-5A82-4DA0-9F66-FF5BF47285DEQ51374167-2B9C0296-E255-4D55-B02F-5B260E313BD1Q54977148-D2B64EB5-D245-46BB-B282-05FADF047719Q55284035-555DE0B5-EDFD-4FF5-9A9F-7C533BF6B6DCQ55425108-05B0DF59-7B2F-41A0-A356-D7CAC7807753
P2860
The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
@en
The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
@nl
type
label
The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
@en
The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
@nl
prefLabel
The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
@en
The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
@nl
P2093
P2860
P1433
P1476
The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies
@en
P2093
Adam M Huber
Childhood Myositis Heterogeneity Collaborative Study Group
Frederick W Miller
Gulnara Mamyrova
Ira N Targoff
Madeline Murguia Rice
P2860
P304
P356
10.1097/MD.0B013E31829D08F9
P407
P577
2013-07-01T00:00:00Z